From the bark of the willow tree 3,500 years ago that Egyptians and Sumerians popularized for pain relief, medicine is one industry that can be counted on for constant innovation...
While minimally invasive treatments transformed cardiology decades ago, advancements in orthopedic medicine are introducing potential alternatives to traditional surgery by applying cellular medicine therapies. GID BIO is focused on using...
AMA grants two Category III CPT® codes, paving the way for reimbursement strategies GID BIO’s unique autologous cellular implant derived from adipose tissue is produced with its SVF-2 device...
Companies and clinics tout the promise of cellular therapy (usually as a "stem cell therapy") backed by little more than anecdotal evidence and the hypothetical possibility of efficacy. When we...